

[ Fri, Nov 29th 2024
] - Tim Hastings
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Bill Williamson
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Phil Bruner
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Thomas Matters
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Thomas Matters
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Bill Williamson
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Brian Stokes
[ Fri, Nov 29th 2024
] - Phil Bruner
[ Fri, Nov 29th 2024
] - Phil Bruner
[ Fri, Nov 29th 2024
] - Phil Bruner
[ Fri, Nov 29th 2024
] - Phil Bruner
[ Fri, Nov 29th 2024
] - Hubert Carizone
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Terrence Williams
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Michael Jones
[ Fri, Nov 29th 2024
] - Phil Bruner
[ Fri, Nov 29th 2024
] - Phil Bruner

[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Hubert Carizone
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Hubert Carizone
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Brian Stokes
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Tim Hastings
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Thomas Matters
[ Thu, Nov 28th 2024
] - Bill Williamson
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Terrence Williams
[ Thu, Nov 28th 2024
] - Michael Jones
[ Thu, Nov 28th 2024
] - Phil Bruner
[ Thu, Nov 28th 2024
] - Phil Bruner
Is Pfizer Stock in Trouble?
- One stock that just can't seem to catch a break of late is Pfizer (NYSE: PFE). Given how well Pfizer has performed in recent years due to its COVID-19 vaccine and pill (its revenue topped $100 billion in 2022),
The article from AOL discusses the challenges faced by Pfizer Inc. as its stock has experienced a significant decline, dropping by 30% in the past year. This downturn is attributed to several factors including the waning demand for its COVID-19 vaccine and treatment, Comirnaty and Paxlovid, as the global health crisis transitions into an endemic phase. Additionally, Pfizer is dealing with patent expirations, increased competition from generic drugs, and a broader market shift away from pharmaceutical stocks. The company's efforts to diversify its portfolio through acquisitions and new product development are highlighted, but these initiatives have not yet offset the revenue loss from its blockbuster drugs. The article also touches on the broader implications for investors, suggesting that while Pfizer faces immediate headwinds, its long-term strategy might still hold promise if new products gain traction.
Read the Full AOL Article at [ https://www.aol.com/pfizer-stock-trouble-111700534.html ]
Read the Full AOL Article at [ https://www.aol.com/pfizer-stock-trouble-111700534.html ]